262 related articles for article (PubMed ID: 18277461)
1. Tolerance in the anxiolytic profile following repeated administration of diazepam but not buspirone is associated with a decrease in the responsiveness of postsynaptic 5-HT-1A receptors.
Khan A; Haleem DJ
Acta Biol Hung; 2007 Dec; 58(4):345-57. PubMed ID: 18277461
[TBL] [Abstract][Full Text] [Related]
2. 5-HT-1A receptor responsiveness following subchronic administration of buspirone.
Khan A; Haleem DJ
Pak J Pharm Sci; 2006 Oct; 19(4):333-7. PubMed ID: 17105715
[TBL] [Abstract][Full Text] [Related]
3. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam.
Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR
Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
[TBL] [Abstract][Full Text] [Related]
6. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
Haleem DJ; Samad N; Haleem MA
Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
[TBL] [Abstract][Full Text] [Related]
7. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
[TBL] [Abstract][Full Text] [Related]
8. Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy.
Haleem DJ; Shireen E; Haleem MA
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1323-9. PubMed ID: 15588759
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of serotonin-1A receptor dependent responses following withdrawal of haloperidol in rats.
Haleem DJ; Khan NH
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):645-51. PubMed ID: 12787852
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
Griebel G; Perrault G; Sanger DJ
Psychopharmacology (Berl); 1998 Jul; 138(1):55-66. PubMed ID: 9694527
[TBL] [Abstract][Full Text] [Related]
11. Serotonin(1A) receptor agonism in the expression of behavioral dopaminergic supersensitivity in subchronic haloperidol treated rats.
Batool F; Haleem DJ
Pak J Pharm Sci; 2008 Oct; 21(4):411-20. PubMed ID: 18930864
[TBL] [Abstract][Full Text] [Related]
12. Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice.
Briones-Aranda A; López-Rubalcava C; Picazo O
Psychopharmacology (Berl); 2002 Jul; 162(2):147-55. PubMed ID: 12110992
[TBL] [Abstract][Full Text] [Related]
13. Activity of Serotonin 5-HT
Jastrzębska-Więsek M; Partyka A; Rychtyk J; Śniecikowska J; Kołaczkowski M; Wesołowska A; Varney MA; Newman-Tancredi A
ACS Chem Neurosci; 2018 May; 9(5):1040-1050. PubMed ID: 29266914
[TBL] [Abstract][Full Text] [Related]
14. The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats.
Kasahara K; Hashimoto S; Hattori T; Kawasaki K; Tsujita R; Nakazono O; Takao K; Kawakubo H; Nagatani T
J Pharmacol Sci; 2015 Jan; 127(1):109-16. PubMed ID: 25704026
[TBL] [Abstract][Full Text] [Related]
15. Anxiolytic activity of SC-48274 compared with those of buspirone and diazepam in experimental anxiety models.
Ogawa N; Hara C; Takaki S
Jpn J Pharmacol; 1993 Feb; 61(2):115-21. PubMed ID: 8096257
[TBL] [Abstract][Full Text] [Related]
16. Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats.
Fernández-Guasti A; Reyes R; Martínez-Mota L; López-Muñoz FJ
Psychopharmacology (Berl); 2005 Jul; 180(3):399-407. PubMed ID: 15719217
[TBL] [Abstract][Full Text] [Related]
17. Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites.
Sato H; Skelin I; Debonnel G; Diksic M
Brain Res Bull; 2008 Mar; 75(5):545-55. PubMed ID: 18355630
[TBL] [Abstract][Full Text] [Related]
18. Buspirone-induced changes in the serotonergic and non-serotonergic cells in the dorsal raphe nucleus of rats.
Jahanshahi A; Lim LW; Steinbusch HW; Visser-Vandewalle V; Temel Y
Neurosci Lett; 2010 Apr; 473(2):136-40. PubMed ID: 20178829
[TBL] [Abstract][Full Text] [Related]
19. Decision time and perseveration of adolescent rats in the T-maze are affected differentially by buspirone and independent of 5-HT-1A expression.
Rhoads DE; Grimes N; Kaushal S; Mallari J; Orlando K
Pharmacol Biochem Behav; 2012 Jul; 102(1):58-63. PubMed ID: 22494991
[TBL] [Abstract][Full Text] [Related]
20. Effects of buspirone, diazepam, and zolpidem on open field behavior, and brain [3H]muscimol binding after buspirone pretreatment.
Siemiatkowski M; Sienkiewicz-Jarosz H; Członkowska AI; Bidziński A; Płaźnik A
Pharmacol Biochem Behav; 2000 Jul; 66(3):645-51. PubMed ID: 10899383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]